Hildur Helgadottir

Hildur Helgadottir

UNVERIFIED PROFILE

Are you Hildur Helgadottir?   Register this Author

Register author
Hildur Helgadottir

Hildur Helgadottir

Publications by authors named "Hildur Helgadottir"

Are you Hildur Helgadottir?   Register this Author

26Publications

566Reads

39Profile Views

Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.

J Natl Cancer Inst 2018 12;110(12):1328-1341

QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy171DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292796PMC
December 2018

Phenocopies in melanoma-prone families with germ-line CDKN2A mutations.

Genet Med 2018 09 7;20(9):1087-1090. Epub 2017 Dec 7.

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/gim.2017.216DOI Listing
September 2018

Personalized Medicine in Malignant Melanoma: Towards Patient Tailored Treatment.

Front Oncol 2018 12;8:202. Epub 2018 Jun 12.

Skin Tumor Center, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2018.00202DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006716PMC
June 2018

Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status.

J Am Acad Dermatol 2017 Nov 14;77(5):893-901. Epub 2017 Aug 14.

Department of Oncology-Pathology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2017.05.050DOI Listing
November 2017

[Increased knowledge on familial melanoma and the underlying genetics].

Lakartidningen 2017 05 9;114. Epub 2017 May 9.

Karolinska Institutet - Stockholm, Sweden Karolinska Institutet - Stockholm, Sweden.

View Article

Download full-text PDF

Source
May 2017

[The melanoma incidence continues to rise].

Lakartidningen 2017 05 9;114. Epub 2017 May 9.

Sahlgrenska universitetssjukhuset - Goteborg, Sweden Sahlgrenska universitetssjukhuset - Goteborg, Sweden.

View Article

Download full-text PDF

Source
May 2017

Germline CDKN2A Mutation Status and Survival in Familial Melanoma Cases.

J Natl Cancer Inst 2016 11 10;108(11). Epub 2016 Jun 10.

Affiliations of authors: Department of Oncology-Pathology, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden (HH, VH, RT, JH); Department of Oncology, Clinical Sciences Lund, Lund University and Skåne University Hospital (GJ, HO); Department of Dermatology, Clinical Sciences Lund, Lund University and Helsingborg Hospital (KN).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw135DOI Listing
November 2016

Robust homology-directed repair within mouse mammary tissue is not specifically affected by Brca2 mutation.

Nat Commun 2016 10 25;7:13241. Epub 2016 Oct 25.

Developmental Biology Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms13241DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093336PMC
October 2016

The genetics of uveal melanoma: current insights.

Appl Clin Genet 2016 6;9:147-55. Epub 2016 Sep 6.

Department of Oncology and Pathology, Karolinska institutet.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/TACG.S69210DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019476PMC
September 2016

The role of germline alterations in the DNA damage response genes BRIP1 and BRCA2 in melanoma susceptibility.

Genes Chromosomes Cancer 2016 07 2;55(7):601-11. Epub 2016 May 2.

Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22363DOI Listing
July 2016

CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.

Int J Cancer 2015 Nov 21;137(9):2220-6. Epub 2015 May 21.

Department of Oncology Pathology, Karolinska Institutet and Karolinska University Hospital, Solna, 171 76, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29595DOI Listing
November 2015

High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.

J Med Genet 2014 Aug 16;51(8):545-52. Epub 2014 Jun 16.

Department of Oncology and Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmedgenet-2014-102320DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112445PMC
August 2014

Hereditary uveal melanoma: a report of a germline mutation in BAP1.

Genes Chromosomes Cancer 2013 Apr 23;52(4):378-84. Epub 2013 Jan 23.

Department of Oncology and Pathology, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22035DOI Listing
April 2013

The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma.

Cancer Immunol Immunother 2009 Oct 13;58(10):1599-608. Epub 2009 Feb 13.

Department of Oncology-Pathology, Karolinska Institute, Radiumhemmet, Karolinska University Hospital, 171 76, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-009-0669-8DOI Listing
October 2009

Tie2Cre-mediated gene ablation defines the stem-cell leukemia gene (SCL/tal1)-dependent window during hematopoietic stem-cell development.

Blood 2005 May 27;105(10):3871-4. Epub 2005 Jan 27.

Division of Hematology-Oncology, Dana-Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-11-4467DOI Listing
May 2005

TGF-beta signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro.

Blood 2003 Nov 3;102(9):3129-35. Epub 2003 Jul 3.

Department of Molecular Medicine and Gene Therapy, Institute of Laboratory Medicine, Lund University Hospital, BMC A12, 221 84 Lund, Sweden.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2003-04-13
Publisher Site
http://dx.doi.org/10.1182/blood-2003-04-1300DOI Listing
November 2003